Wolfgang H. B. Sauer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wolfgang H. B. Sauer has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
Agnes Bombrun
Chemistry Department, Merck Serono S.A. 9 Chemin des Mines, 1202 Geneva (Switzerland)
3 shared publicationsAnthony Nichols
Lead Discovery Technologies, Merck Serono S.A. 9 Chemin des Mines, 1202 Geneva (Switzerland)
3 shared publications- Agnes Bombrun
Agnes Bombrun, Merck Serono S.A. Geneva, 9 Chemin des mines 1202 Geneva (Switzerland)
2 shared publications - Anna Quattropani
Chemistry Department, Merck Serono S.A. 9 Chemin des Mines, 1202 Geneva (Switzerland)
2 shared publications Delphine Marin
Chemistry Department, Merck Serono S.A. 9 Chemin des Mines, 1202 Geneva (Switzerland)
2 shared publicationsDominique Swinnen
Merck Serono SA, 9 Chem. des Mines, 1202 Geneva, Switzerland
2 shared publications
Latest Publications
- 3 March 2015
- Published by Wiley in ChemMedChem
- Vol. 10 (4) , 688-714
Pharmacophore-Based Design of Novel Oxadiazoles as Selective Sphingosine-1-phosphate (S1P) Receptor Agonists with in vivo Efficacy
- 3 March 2015
- Published by Wiley in ChemMedChem
- Vol. 10 (4) , 688-714
Pharmacophore-Based Design of Novel Oxadiazoles as Selective Sphingosine-1-phosphate (S1P) Receptor Agonists with in vivo Efficacy
- 13 February 2014
- Published by Wiley in Chemistry – A European Journal
- Vol. 20 (13) , 3813-3824
Enantioselective Synthesis and Physicochemical Properties of Libraries of 3‐Amino‐ and 3‐Amidofluoropiperidines
The enantioselective syntheses of 3‐amino‐5‐fluoropiperidines and 3‐amino‐5,5‐difluoropiperidines were developed using the ring enlargement of prolinols to access libraries of 3‐amino‐ and 3‐amidofluoropiperidines. The study of the physicochemical properties revealed that fluorine atom(s) decrease(s) the pKa and modulate(s) the lipophilicity of 3‐aminopiperidines. The relative stereochemistry of the fluorine atoms with the amino groups at C3 on the piperidine core has a small effect on the pKa due to conformationnal modifications induced by fluorine atom(s). In the protonated forms, the CF bond is in an axial position due to a dipole–dipole interaction between the N−H+ and CF bonds. Predictions of the physicochemical properties using common software appeared to be limited to determine correct values of pKa and/or differences of pKa between cis‐ and trans‐3‐amino‐5‐fluoropiperidines.
- 13 February 2014
- Published by Wiley in Chemistry – A European Journal
- Vol. 20 (13) , 3813-3824
Enantioselective Synthesis and Physicochemical Properties of Libraries of 3‐Amino‐ and 3‐Amidofluoropiperidines
The enantioselective syntheses of 3‐amino‐5‐fluoropiperidines and 3‐amino‐5,5‐difluoropiperidines were developed using the ring enlargement of prolinols to access libraries of 3‐amino‐ and 3‐amidofluoropiperidines. The study of the physicochemical properties revealed that fluorine atom(s) decrease(s) the pKa and modulate(s) the lipophilicity of 3‐aminopiperidines. The relative stereochemistry of the fluorine atoms with the amino groups at C3 on the piperidine core has a small effect on the pKa due to conformationnal modifications induced by fluorine atom(s). In the protonated forms, the CF bond is in an axial position due to a dipole–dipole interaction between the N−H+ and CF bonds. Predictions of the physicochemical properties using common software appeared to be limited to determine correct values of pKa and/or differences of pKa between cis‐ and trans‐3‐amino‐5‐fluoropiperidines.
- 27 June 2013
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 27 (6) , 511-524
Protein pocket and ligand shape comparison and its application in virtual screening
Understanding molecular recognition is one major requirement for drug discovery and design. Physicochemical and shape complementarity between two binding partners is the driving force during complex formation. In this study, the impact of shape within this process is analyzed. Protein binding pockets and co-crystallized ligands are represented by normalized principal moments of inertia ratios (NPRs). The corresponding descriptor space is triangular, with its corners occupied by spherical, discoid, and elongated shapes. An analysis of a selected set of sc-PDB complexes suggests that pockets and bound ligands avoid spherical shapes, which are, however, prevalent in small unoccupied pockets. Furthermore, a direct shape comparison confirms previous studies that on average only one third of a pocket is filled by its bound ligand, supplemented by a 50 % subpocket coverage. In this study, we found that shape complementary is expressed by low pairwise shape distances in NPR space, short distances between the centers-of-mass, and small deviations in the angle between the first principal ellipsoid axes. Furthermore, it is assessed how different binding pocket parameters are related to bioactivity and binding efficiency of the co-crystallized ligand. In addition, the performance of different shape and size parameters of pockets and ligands is evaluated in a virtual screening scenario performed on four representative targets.
- 27 June 2013
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 27 (6) , 511-524
Protein pocket and ligand shape comparison and its application in virtual screening
Understanding molecular recognition is one major requirement for drug discovery and design. Physicochemical and shape complementarity between two binding partners is the driving force during complex formation. In this study, the impact of shape within this process is analyzed. Protein binding pockets and co-crystallized ligands are represented by normalized principal moments of inertia ratios (NPRs). The corresponding descriptor space is triangular, with its corners occupied by spherical, discoid, and elongated shapes. An analysis of a selected set of sc-PDB complexes suggests that pockets and bound ligands avoid spherical shapes, which are, however, prevalent in small unoccupied pockets. Furthermore, a direct shape comparison confirms previous studies that on average only one third of a pocket is filled by its bound ligand, supplemented by a 50 % subpocket coverage. In this study, we found that shape complementary is expressed by low pairwise shape distances in NPR space, short distances between the centers-of-mass, and small deviations in the angle between the first principal ellipsoid axes. Furthermore, it is assessed how different binding pocket parameters are related to bioactivity and binding efficiency of the co-crystallized ligand. In addition, the performance of different shape and size parameters of pockets and ligands is evaluated in a virtual screening scenario performed on four representative targets.
- Open Access
- 17 November 2012
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 41 (D1) , D1137-D1143
SwissBioisostere: a database of molecular replacements for ligand design
The SwissBioisostere database (http://www.swissbioisostere.ch) contains information on molecular replacements and their performance in biochemical assays. It is meant to provide researchers in drug discovery projects with ideas for bioisosteric modifications of their current lead molecule, as well as to give interested scientists access to the details on particular molecular replacements. As of August 2012, the database contains 21 293 355 datapoints corresponding to 5 586 462 unique replacements that have been measured in 35 039 assays against 1948 molecular targets representing 30 target classes. The accessible data were created through detection of matched molecular pairs and mining bioactivity data in the ChEMBL database. The SwissBioisostere database is hosted by the Swiss Institute of Bioinformatics and available via a web-based interface.
- 17 November 2012
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 41 (D1) , D1137-D1143
Open AccessSwissBioisostere: a database of molecular replacements for ligand design
The SwissBioisostere database (http://www.swissbioisostere.ch) contains information on molecular replacements and their performance in biochemical assays. It is meant to provide researchers in drug discovery projects with ideas for bioisosteric modifications of their current lead molecule, as well as to give interested scientists access to the details on particular molecular replacements. As of August 2012, the database contains 21 293 355 datapoints corresponding to 5 586 462 unique replacements that have been measured in 35 039 assays against 1948 molecular targets representing 30 target classes. The accessible data were created through detection of matched molecular pairs and mining bioactivity data in the ChEMBL database. The SwissBioisostere database is hosted by the Swiss Institute of Bioinformatics and available via a web-based interface.
- 1 September 2012
- Published by Elsevier in Tetrahedron Letters
- Vol. 53 (37) , 5030-5033
Highly efficient and chemoselective acetalization and thioacetalization of aldehydes catalyzed by propylphosphonic anhydride (®T3P) at room temperature
- 1 September 2012
- Published by Elsevier in Tetrahedron Letters
- Vol. 53 (37) , 5030-5033
Highly efficient and chemoselective acetalization and thioacetalization of aldehydes catalyzed by propylphosphonic anhydride (®T3P) at room temperature
- 12 July 2011
- Published by Wiley in Molecular Informatics
- Vol. 30 (8) , 677-688
Bioactive Molecules: Perfectly Shaped for Their Target?
In this study, we examined target subsets extracted from the MDL Drug Data Report (MDDR)1 to identify specific molecular shape profiles that are representative for compounds active on those targets. Normalized Principal Moments of Inertia Ratios (NPRs)2 have been used to describe molecular shape of small molecules in a finite triangular descriptor space. The clustering behavior of the MDDR target subsets in a cell‐based triangular system shows a significant difference compared to randomly sampled datasets and proves the capability of the NPR descriptor to provide information. For some of the target subsets, certain parts of the descriptor space are unlikely to be occupied by bioactive compounds. All analyzed datasets show a generally biased distribution of molecular shapes: the majority of their compounds exhibit a rod‐like character. The influence of the employed 3D conformer generators on this distribution has been assessed as well as the capability of multiple conformations of compounds to increase the shape space covered.
- 12 July 2011
- Published by Wiley in Molecular Informatics
- Vol. 30 (8) , 677-688
Bioactive Molecules: Perfectly Shaped for Their Target?
In this study, we examined target subsets extracted from the MDL Drug Data Report (MDDR)1 to identify specific molecular shape profiles that are representative for compounds active on those targets. Normalized Principal Moments of Inertia Ratios (NPRs)2 have been used to describe molecular shape of small molecules in a finite triangular descriptor space. The clustering behavior of the MDDR target subsets in a cell‐based triangular system shows a significant difference compared to randomly sampled datasets and proves the capability of the NPR descriptor to provide information. For some of the target subsets, certain parts of the descriptor space are unlikely to be occupied by bioactive compounds. All analyzed datasets show a generally biased distribution of molecular shapes: the majority of their compounds exhibit a rod‐like character. The influence of the employed 3D conformer generators on this distribution has been assessed as well as the capability of multiple conformations of compounds to increase the shape space covered.
- 1 March 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (5) , 1516-1519
Discovery of a novel series of potent S1P1 agonists
- 1 March 2010
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (5) , 1516-1519
Discovery of a novel series of potent S1P1 agonists
- Open Access
- 1 December 2006
- Published by Elsevier in SLAS Discovery
- Vol. 11 (8) , 996-1004
A Microfluidics-Based Mobility Shift Assay to Discover New Tyrosine Phosphatase Inhibitors
- 1 December 2006
- Published by Elsevier in SLAS Discovery
- Vol. 11 (8) , 996-1004
Open AccessA Microfluidics-Based Mobility Shift Assay to Discover New Tyrosine Phosphatase Inhibitors
- 26 November 2004
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (27) , 6921-6934
Design, Synthesis, and Biological Activity of Novel, Potent, and Selective (Benzoylaminomethyl)thiophene Sulfonamide Inhibitors of c-Jun-N-Terminal Kinase
Several lines of evidence support the hypothesis that c-Jun N-terminal kinases (JNKs) play a critical role in a wide range of disease states including cell death (apoptosis)-related and inflammatory disorders (epilepsy, brain, heart and renal ischemia, neurodegenerative diseases, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel syndrome). The screening of a compound collection led to the identification of a 2-(benzoylaminomethyl)thiophene sulfonamide (AS004509, compound I) as a potent and selective JNK inhibitor. Chemistry and structure−activity relationship (SAR) studies performed around this novel kinase-inhibiting motif indicated that the left and central parts of the molecule were instrumental to maintaining potency at the enzyme. Accordingly, we investigated the JNK-inhibiting properties of a number of variants of the right-hand moiety of the molecule, which led to the identification of 2-(benzoylaminomethyl)thiophene sulfonamide benzotriazole (AS600292, compound 50a), the first potent and selective JNK inhibitor of this class which demonstrates a protective action against neuronal cell death induced by growth factor and serum deprivation.
- 26 November 2004
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (27) , 6921-6934
Design, Synthesis, and Biological Activity of Novel, Potent, and Selective (Benzoylaminomethyl)thiophene Sulfonamide Inhibitors of c-Jun-N-Terminal Kinase
Several lines of evidence support the hypothesis that c-Jun N-terminal kinases (JNKs) play a critical role in a wide range of disease states including cell death (apoptosis)-related and inflammatory disorders (epilepsy, brain, heart and renal ischemia, neurodegenerative diseases, multiple sclerosis, rheumatoid arthritis, and inflammatory bowel syndrome). The screening of a compound collection led to the identification of a 2-(benzoylaminomethyl)thiophene sulfonamide (AS004509, compound I) as a potent and selective JNK inhibitor. Chemistry and structure−activity relationship (SAR) studies performed around this novel kinase-inhibiting motif indicated that the left and central parts of the molecule were instrumental to maintaining potency at the enzyme. Accordingly, we investigated the JNK-inhibiting properties of a number of variants of the right-hand moiety of the molecule, which led to the identification of 2-(benzoylaminomethyl)thiophene sulfonamide benzotriazole (AS600292, compound 50a), the first potent and selective JNK inhibitor of this class which demonstrates a protective action against neuronal cell death induced by growth factor and serum deprivation.
- 20 July 2004
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (17) , 4142-4146
Prospects for Inhibitors of Protein Tyrosine Phosphatase 1B as Antidiabetic Drugs
- 20 July 2004
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (17) , 4142-4146
Prospects for Inhibitors of Protein Tyrosine Phosphatase 1B as Antidiabetic Drugs